 Connection
Rebecca Rentea to Hirschsprung Disease
This is a "connection" page, showing publications Rebecca Rentea has written about Hirschsprung Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
8.893 |
|
|
|
-
Bokova E, Prasade N, Lewis WE, Feira CN, Lim IIP, Oyetunji TA, Rentea RM. Evaluation of Post-neonatal Intensive Care Unit Home Irrigations Prior to Pull-through: Implications for Hirschsprung Disease Management. J Pediatr Surg. 2024 Jul; 59(7):1245-1249.
Score: 0.887
-
Svetanoff WJ, Lim-Beutal IIP, Wood RJ, Levitt MA, Rentea RM. The utilization of botulinum toxin for Hirschsprung disease. Semin Pediatr Surg. 2022 Apr; 31(2):151161.
Score: 0.776
-
Svetanoff WJ, Lopez JJ, Briggs KB, Fraser JA, Fraser JD, Oyetunji TA, Peter SDS, Rentea RM. Management of Hirschsprung associated enterocolitis-How different are practice strategies? An international pediatric endosurgery group (IPEG) survey. J Pediatr Surg. 2022 Jun; 57(6):1119-1126.
Score: 0.768
-
Svetanoff WJ, Briggs K, Fraser JA, Lopez J, Fraser JD, Juang D, Aguayo P, Hendrickson RJ, Snyder CL, Oyetunji TA, St Peter SD, Rentea RM. Outpatient Botulinum Injections for Early Obstructive Symptoms in Patients with Hirschsprung Disease. J Surg Res. 2022 01; 269:201-206.
Score: 0.748
-
Svetanoff WJ, Lopez J, Aguayo P, Hendrickson RJ, Oyetunji TA, Rentea RM. The impact of botulinum injection for hospitalized children with Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2021 Oct; 37(10):1467-1472.
Score: 0.739
-
Svetanoff WJ, Kapalu CL, Lopez JJ, Fraser JA, Briggs KB, Rentea RM. Psychosocial factors affecting quality of life in patients with anorectal malformation and Hirschsprung disease-a qualitative systematic review. J Pediatr Surg. 2022 Mar; 57(3):387-393.
Score: 0.730
-
Svetanoff WJ, Rentea RM. Post-operative enterocolitis in Hirschsprung's disease: response to a Letter to the Editor. Pediatr Surg Int. 2021 04; 37(4):527-528.
Score: 0.717
-
Rentea RM, Noel-MacDonnell JR, Bucher BT, Dorman MR, Lautz TB, Pruitt LCC, Oyetunji TA. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through. J Surg Res. 2021 05; 261:95-104.
Score: 0.711
-
Svetanoff WJ, Dekonenko C, Osuchukwu O, Oyetunji TA, Aguayo P, Fraser JD, Juang D, Snyder CL, Hendrickson R, Peter SS, Rentea RM. Inpatient management of Hirschsprung's associated enterocolitis treatment: the benefits of standardized care. Pediatr Surg Int. 2020 Dec; 36(12):1413-1421.
Score: 0.698
-
Rentea RM, Halleran DR, Ahmad H, Sanchez AV, Gasior AC, McCracken K, Hewitt GD, Alexander V, Smith C, Weaver L, Wood RJ, Levitt MA. Preliminary Use of Indocyanine Green Fluorescence Angiography and Value in Predicting the Vascular Supply of Tissues Needed to Perform Cloacal, Anorectal Malformation, and Hirschsprung Reconstructions. Eur J Pediatr Surg. 2020 Dec; 30(6):505-511.
Score: 0.661
-
Ullrich S, Austin K, Avansino JR, Badillo A, Calkins CM, Crady RC, Durham MM, Fuller MK, Rana A, Reeder RW, Rentea RM, Rollins MD, Saadai P, Speck KE, Wood RJ, van Leeuwen K, Frischer JS. Does Delayed Diagnosis of Hirschsprung Disease Impact Post-operative and Functional Outcomes? A Multi-Center Review From the Pediatric Colorectal and Pelvic Learning Consortium. J Pediatr Surg. 2024 Jul; 59(7):1250-1255.
Score: 0.222
-
Sutthatarn P, Lapidus-Krol E, Smith C, Halaweish I, Rialon K, Ralls MW, Rentea RM, Madonna MB, Haddock C, Rocca AM, Gosain A, Frischer J, Piper H, Goldstein AM, Saadai P, Durham MM, Dickie B, Jafri M, Langer JC. Hirschsprung-associated inflammatory bowel disease: A multicenter study from the APSA Hirschsprung disease interest group. J Pediatr Surg. 2023 May; 58(5):856-861.
Score: 0.205
-
Rice-Townsend SE, Nicassio L, Glazer D, Avansino J, Durham MM, Calkins CM, Rentea RM, Ralls MW, Wood RJ, Rollins MD, Garvey EM, Lewis KE, Reeder R, Smith CA. Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery. J Pediatr Surg. 2022 Jun; 57(6):1033-1039.
Score: 0.192
-
Ahmad H, Rentea RM, Knaus ME, Wilbur JG, Halaweish I, Langer JC, Levitt MA, Wood RJ. Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis. J Pediatr Surg. 2022 Aug; 57(8):1453-1457.
Score: 0.190
-
Kastenberg ZJ, Taylor MA, Durham MM, Calkins CM, Rentea RM, Wood RJ, Avansino JR, Levitt MA, van Leeuwen KD, Lewis KE, Reeder RW, Rollins MD. Perioperative and long-term functional outcomes of neonatal versus delayed primary endorectal pull-through for children with Hirschsprung disease: A pediatric colorectal and pelvic learning consortium study. J Pediatr Surg. 2021 Aug; 56(8):1465-1469.
Score: 0.182
-
Kawaguchi AL, Guner YS, S?mme S, Quesenberry AC, Arthur LG, Sola JE, Downard CD, Rentea RM, Valusek PA, Smith CA, Slidell MB, Ricca RL, Dasgupta R, Renaud E, Miniati D, McAteer J, Beres AL, Grabowski J, Peter SDS, Gosain A. Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee. J Pediatr Surg. 2021 Sep; 56(9):1513-1523.
Score: 0.181
-
Vilanova-Sanchez A, Ivanov M, Halleran DR, Wagner A, Reck-Burneo CA, Ruth B, FIsher M, Ahmad H, Weaver L, Nash O, Buker D, Rentea RM, Hoover E, Maloof T, Wood RJ, Levitt MA. Total Colonic Hirschsprung's Disease: The Hypermotility and Skin Rash Protocol. Eur J Pediatr Surg. 2020 Aug; 30(4):309-316.
Score: 0.162
-
Antiel RM, Blinman TA, Rentea RM, Gonzalez KW, Knott EM, Juang D, Oyetunji T, Holcomb GW, Angelos P, Lantos JD. When a Surgical Colleague Makes an Error. Pediatrics. 2016 Mar; 137(3):e20153828.
Score: 0.126
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|